Zobrazeno 1 - 10
of 121
pro vyhledávání: ''
Autor:
Stephen J. Forman, Ellen K Chang, Kelly Peng, Saro H. Armenian, LiYing Cai, Ryotaro Nakamura, Aleksi Iukuridze, Dayana Chanson, Jennifer Berano Teh, F. Lennie Wong
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(8)
PURPOSE To examine the incidence and risk factors for de novo atrial fibrillation (AF) after allogeneic hematopoietic cell transplantation (HCT) and to describe the impact of AF on HCT-related outcomes. METHODS A retrospective cohort study design was
Autor:
Rammurti T. Kamble, Baldeep Wirk, Martin S. Tallman, Taiga Nishihori, Celalettin Ustun, Brian C. Shaffer, Andrew Daly, Mark R. Litzow, Basem M. William, Michael R. Grunwald, Ravi Vij, Ulrike Bacher, David I. Marks, Richard T. Maziarz, Tamila L. Kindwall-Keller, Uday R. Popat, David A. Rizzieri, Ayman Saad, William A. Wood, Omotayo Fasan, Mitchell Sabloff, Wael Saber, Corey Cutler, Jorge E. Cortes, Ronald Sobecks, Ran Reshef, Jean-Yves Cahn, Jane L. Liesveld, Zhen-Huan Hu, Matt Kalaycio, Betty K. Hamilton, Richard F. Olsson, Adriana K. Malone, Edwin P. Alyea, Bipin N. Savani, Erica D. Warlick, Steven Z. Pavletic, Edward A. Copelan, Aaron T. Gerds, Robert Peter Gale, Alan M. Miller, Kwang Woo Ahn, Luciano J. Costa, Peter H. Wiernik, David Valcárcel, Mohamed A. Kharfan-Dabaja
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(16)
Purpose To develop a system prognostic of outcome in those undergoing allogeneic hematopoietic cell transplantation (allo HCT) for myelodysplastic syndrome (MDS). Patients and Methods We examined 2,133 patients with MDS undergoing HLA-matched (n = 1,
Autor:
Rachel Wuerstlein, Michael J. Clemens, Ulrike Nitz, Daniel Hofmann, Bahriye Aktas, Ronald E. Kates, F Lorenz-Salehi, V. Heyl, M Kusche, Toralf Reimer, Hans Kreipe, Stefan Kraemer, Steven Shak, Oleg Gluz, Marianne Just, Cornelia Liedtke, Sherko Kuemmel, Nadia Harbeck, Matthias Christgen, Tom Degenhardt, Christer Svedman
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(20)
Purpose The 21-gene Recurrence Score (RS) assay is a validated prognostic/predictive tool in early hormone receptor–positive breast cancer (BC); however, only a few prospective outcome results have been available so far. In the phase III PlanB tria
Autor:
Karen Juul Mylam, Peter de Nully Brown, Martin Bøgsted, Martin Hutchings, Mats Jerkeman, Viktoria Hjalmar, Hans Erik Johnsen, Elisabeth Székely, Lasse Hjort Jakobsen, Herman Nilsson-Ehle, Tarec Christoffer El-Galaly
Publikováno v:
El-Galaly, T C, Jakobsen, L H, Hutchings, M, de Nully Brown, P, Nilsson-Ehle, H, Székely, E, Mylam, K J, Hjalmar, V, Johnsen, H E, Bøgsted, M & Jerkeman, M 2015, ' Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival : A Danish-Swedish Population-Based Study ', Journal of Clinical Oncology, vol. 33, no. 34, pp. 3993-3998 . https://doi.org/10.1200/JCO.2015.62.0229
Purpose Routine imaging for diffuse large B-cell lymphoma (DLBCL) in first complete remission (CR) is controversial and plays a limited role in detecting relapse. This population-based study compared the survival of Danish and Swedish patients with D
Autor:
Jan Maxwell Nørgaard, Mette K. Andersen, Birgitte Preiss, Lone Smidstrup Friis, Marianne Tang Severinsen, Lene Sofie Granfeldt Østgård, Mette Nørgaard, Inge Høgh Dufva, Claus Werenberg Marcher, Bruno C. Medeiros, H Sengeløv, Eigil Kjeldsen
Publikováno v:
Granfeldt Østgård, L S, Medeiros, B C, Sengeløv, H, Nørgaard, M, Andersen, M K, Dufva, I H, Friis, L S, Kjeldsen, E, Marcher, C W, Preiss, B, Severinsen, M & Nørgaard, J M 2015, ' Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia : A National Population-Based Cohort Study ', Journal of Clinical Oncology, vol. 33, no. 31, pp. 3641-3649 . https://doi.org/10.1200/JCO.2014.60.0890
Granfeldt Østgård, L S, Medeiros, B C, Sengeløv, H, Nørgaard, M, Andersen, M K, Dufva, I H, Friis, L S, Kjeldsen, E, Marcher, C W, Preiss, B, Severinsen, M & Nørgaard, J M 2015, ' Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia : A National Population-Based Cohort Study ', Journal of Clinical Oncology, vol. 33, no. 31, pp. 3641-9 . https://doi.org/10.1200/JCO.2014.60.0890
Granfeldt Østgård, L S, Medeiros, B C, Sengeløv, H, Nørgaard, M, Andersen, M K, Dufva, I H, Friis, L S, Kjeldsen, E, Marcher, C W, Preiss, B, Severinsen, M & Nørgaard, J M 2015, ' Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia : A National Population-Based Cohort Study ', Journal of Clinical Oncology, vol. 33, no. 31, pp. 3641-9 . https://doi.org/10.1200/JCO.2014.60.0890
Purpose Secondary and therapy-related acute myeloid leukemia (sAML and tAML, respectively) remain therapeutic challenges. Still, it is unclear whether their inferior outcome compared with de novo acute myeloid leukemia (AML) varies as a result of pre
Autor:
Sigurdur Y. Kristinsson, J. Samuelsson, Ola Landgren, Sally R. Wilkes, Therese M.-L. Andersson, Sandra Eloranta, Magnus Björkholm, Asa Rangert Derolf, Malin Hultcrantz, Paul Lambert, Paul W. Dickman
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(20)
Purpose Myeloproliferative neoplasms (MPNs) are associated with a shortened life expectancy. We assessed causes of death in patients with MPN and matched controls using both relative risks and absolute probabilities in the presence of competing risks
Autor:
Tomohide Tamura, Hiroshi Nokihara, Yasuhide Yamada, Noboru Yamamoto, Hidenori Mizugaki, Yutaka Fujiwara
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(18)
Purpose In Japan, phase I trials, except first-in-human trials, are usually initiated from approximately 50% of the maximum-tolerated dose (MTD) or maximum administered dose (MAD) determined during the initial phase I trials in North America and Euro
Autor:
Gabriella Cohn-Cedermark, Scott Tyldesley, Andrew Protheroe, Craig R. Nichols, Peter Chung, Philippe L. Bedard, Siamak Daneshmand, Michael A.S. Jewett, T. Tandstad, Padraig Warde, Kim N. Chi, Alan I. So, Thomas Powles, M. J. Moore, Peter C. Black, Christian Kollmannsberger
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(1)
Purpose To evaluate the performance of active surveillance as a management strategy in broad populations and to inform the development of surveillance schedules by individual patient data regarding timing and type of relapse. Methods Retrospective st
Autor:
Pier Luigi Zinzani, Alberto Biggi, Annika Loft, Morton Coleman, Louis F. Diehl, Lena Specht, C. Nanni, Myron S. Czuczman, Iwona Danielewicz, L. Kostakoglu, Jan Maciej Zaucha, Dominick Lamonica, Richard Stern, Bogdan Małkowski, Martin Hutchings
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(25)
Purpose Negative [18F]fluorodeoxyglucose (FDG) –positron emission tomography (PET)/computed tomography (CT) after two cycles of chemotherapy indicates a favorable prognosis in Hodgkin lymphoma (HL). We hypothesized that the negative predictive valu
Autor:
Ramaprasad Srinivasan, James Peterson, Maria J. Merino, W. Marston Linehan, Srinivas Vourganti, Christopher J. Ricketts, Lindsay Middleton, Adam R. Metwalli, Brian Shuch
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(5)
Purpose Approximately 5% to 8% of renal cell carcinoma (RCC) is hereditary. No guidelines exist for patient selection for RCC germline mutation testing. We evaluate how age of onset could indicate the need for germline mutation testing for detection